Learn how pharma and medical AI teams can turn archived clinical trial imaging into searchable, governed, AI-ready data for reuse.
Learn how sponsors and CROs can spot redundant imaging QC steps, cut delays, and catch imaging problems while they can still be corrected.
Learn why longitudinal imaging workflows in neuro-oncology clinical trials need a subject-centric approach to improve consistency, traceability, and...
Explore how RANO 2.0, AI-assisted imaging, and evolving regulatory expectations are changing neuro-oncology clinical trials and imaging workflows.
QMENTA vs. Quibim: A strategic comparison of two medical imaging AI platforms — reproducible CNS trial endpoints vs. hospital radiology diagnostics.
QMENTA launches Central Review to address the longitudinal consistency problem that derails long-duration oncology and CNS trials
Conversations at ISMRM 2026 revealed growing challenges around imaging data sharing, interoperability, federated learning, and scalable MRI research...
Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...